Micron Technology's stock has skyrocketed over 360% in the past year, fueled by insatiable AI-driven demand for memory chips. But with shares now trading at a significant premium to some traditional valuation models, investors face a critical question: has the rally run too far, too fast?
While the FTSE 100 grapples with global headwinds, a segment of smaller UK-listed companies presents distinct opportunities. We examine three firms, each with a market capitalisation over £90 million, that combine financial resilience with specific growth catalysts.
Italian Prime Minister Giorgia Meloni and German Chancellor Friedrich Merz have signed a landmark partnership pact in Rome, signaling a potential shift in the European Union's traditional Franco-German power center. The accord, focusing on defense, migration, and trade, comes as France grapples with political instability and a weakened presidency.
Laura Fernandez, a close ally of outgoing populist President Rodrigo Chaves, has been elected Costa Rica's next leader. She pledges to continue his transformative agenda, including constitutional reforms and emergency measures to combat drug violence, signaling a profound shift for the nation.
Nepali authorities have arrested six executives from travel and rescue companies, alleging a sophisticated fraud scheme involving fabricated high-altitude rescues to bilk international insurers out of nearly $20 million.
A Russian drone attack on a bus carrying Ukrainian miners home from work has left at least 12 dead and 8 wounded, officials say, in what is being condemned as a deliberate strike on civilians.
As markets look ahead to 2026, a mix of established giants and emerging players in AI and digital advertising present compelling opportunities for investors seeking both growth and value.
The Swiss interdealer broker has delivered a stellar 213% total shareholder return since 2021, fueled by market confidence and robust dividends, despite recent slight pullback.
Precious metals continue their sharp retreat from January's record highs, with silver leading the decline as market sentiment shifts following key U.S. policy signals.
The Singapore-listed food company has turned profitable after years of losses, with a 12% return on capital employed and a significant expansion in its capital base—key indicators watched by investors seeking compounding growth stocks.
Snapchat has disabled hundreds of thousands of accounts belonging to users under 16 in Australia under new social media laws, but warns the legislation contains 'significant gaps' that may allow some minors to bypass protections.
As Thailand heads to the polls, three major parties offer starkly different visions for the nation's path forward, from populist subsidies to structural reforms, setting the stage for a pivotal political contest.
As the pet care market expands, investors weigh the focused approach of Chewy against Walmart's diversified scale. While Chewy offers pure exposure, Walmart's broader ecosystem and advertising growth present a compelling alternative.
Lucky Strike Entertainment's stock has tumbled nearly 24% over the past year, raising critical questions about its true worth. We analyze whether the current price reflects underlying value or signals an overextended valuation.
Shares of SBA Communications have faced persistent pressure, declining over 5% in the past year. A detailed analysis of its discounted cash flow and P/E ratio suggests the wireless infrastructure REIT may be significantly undervalued, presenting a potential entry point for long-term investors.
Shares of insulin pump maker Tandem Diabetes Care have plummeted over 80% in five years, trading near $20. A deep dive into valuation metrics suggests the stock may now be modestly undervalued, but significant risks and competitive pressures remain.
Shares of PROG Holdings (PRG) have rallied sharply in recent months, prompting investors to scrutinize whether the fintech company's current valuation reflects its underlying fundamentals or is simply riding a wave of market momentum.
After a recent pullback, Landstar System's (LSTR) shares present a complex valuation picture. While short-term momentum has improved, the stock trades at a significant premium to industry P/E ratios, raising questions about its growth prospects amid a mixed freight demand environment.
Travere Therapeutics faces a securities fraud investigation by Robbins Geller Rudman & Dowd LLP, raising questions about the accuracy of its past disclosures. The probe casts a shadow over the company's critical transition, as it banks on its kidney drug FILSPARI to drive growth amid mounting legal and commercial pressures.
Shares of Advantest Corp. have surged nearly 200% in the past year, riding the AI and advanced chipmaking wave. As the stock trades near record highs, investors are grappling with a critical question: has the rally run too far, too fast?
